ST RENATUS LLC has a total of 41 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2010. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and medical technology are GLENMARK SPECIALTY SA, ALEXZA MOLECULAR DELIVERY CORP and BLUEBERRY THERAPEUTICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Australia | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Canada | 3 | |
#5 | China | 3 | |
#6 | EPO (European Patent Office) | 3 | |
#7 | Republic of Korea | 3 | |
#8 | New Zealand | 3 | |
#9 | South Africa | 3 | |
#10 | Brazil | 2 | |
#11 | Israel | 2 | |
#12 | Mexico | 2 | |
#13 | EAPO (Eurasian Patent Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Kollar Mark David | 24 |
#2 | Kollar Mark D | 12 |
#3 | Mark David Kollar | 2 |
#4 | Mark D Kollar | 1 |
Publication | Filing date | Title |
---|---|---|
WO2017210390A1 | Intranasal dental anesthetic | |
WO2016105482A1 | Tetracaine-based anesthetic | |
US2015246017A1 | Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines | |
CN103932973A | Dental Anesthetic Comprising Tetracaine And A Vasoconstrictor For Intranasal Administration |